Top of page

IP & Commercial Transactions

Practice

Filters

Atea Pharmaceuticals $345 million IPO

Davis Polk advised the representatives of the underwriters in connection with the $345 million initial public offering of 14…

Biodesix $72 million IPO

Davis Polk advised the joint book-running managers and representatives of the several underwriters on the $72 million…
Back to top